Marino F, Cosentino M. Adrenergic modulation of immune
cells: an update. Amino Acids. 2013;45:55–71.
Schuller HM, Cole B. Regulation of cell proliferation by βadrenergic receptors in a human lung adenocarcinoma cell
line. Carcinogenesis. 1989;10:1753–1755.
Wrobel LJ, Le Gal FA. Inhibition of human melanoma growth
by a non-cardioselective β-blocker. J Invest Dermatol. 2015;135
(2):525–531.
De Giorgi V, Grazzini M, Gandini S, et al. Treatment with βblockers and reduced disease progression in patients with
thick melanoma. Arch...
De Giorgi V, Grazzini M, Benemei S, Marchionni N, Geppetti P,
Gandini S. β-Blocker use and reduced disease progression in
patients with thick...
De Giorgi V, Gandini S, Grazzini M, Benemei S, Marchionni N,
Geppetti P. Effect of β-blockers and other antihypertensive
drugs on the risk...
De Giorgi V, Grazzini M, Benemei S, et al. Propranolol for offlabel treatment of patients with melanoma: results from a
cohort study. JAMA...
Lemeshow S, Sørensen HT, Phillips G, et al. β-Blockers and
survival among danish patients with malignant melanoma:
a population-based cohort...
Livingstone E, Hollestein LM, Van Herk-Sukel MP, et al. βBlocker use and all-cause mortality of melanoma patients:
results from a population-based...
McCourt C, Coleman HG, Murray LJ, et al. β-Blocker usage after
malignant melanoma diagnosis and survival: a populationbased nested case –...
Moser JC, Dronca RS, Markovic SN, Mansfield AS. Effect of
betaadrenergic blockers and other antihypertensive drugs on
the risk of melanoma...
Suissa S. Immortal time bias in pharmaco-epidemiology. Am J
Epidemiol. 2008;167:492–499.
Weberpals J, Jansen L, Carr PR, Hoffmeister M, Brenner H. β
blockers and cancer prognosis – the role of immortal time
bias: a systematic review...
Na Z, et al. Los efectos del uso de betabloqueantes en el
pronóstico del cáncer: un metaanálisis basado en 319.006
pacientes. Onco Targets...
Patel VG, Oh WK, Galsky MD, Liaw BCH, Tsao CK. Effect of
concurrent β-blocker (BB) use in patients receiving immune
checkpoint inhibitors...
Gandhi S, Pandey M, Ammannagari N, et al. Impact of
concomitant medication use and immune-related adverse
events on response to immune checkpoint...
Failing JJ, Finnes HD, Kottschade LA, Allred JB, Markovic SN.
Effects of commonly used chronic medications on the
outcomes of ipilimumab therapy...
Kokolus KM, Zhang Y, Sivik JM, et al. El uso de bloqueadores β
se correlaciona con una mejor supervivencia general en
pacientes con melanoma...